Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
32.6%
% of IDNA's 51 holdings also in CNCR
20.8%
% of CNCR's 72 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 4.9% | 2.7% | 2.7% |
|
SPRINGWORKS THERAPEUTICS, INC. | 5.0% | 2.7% | 2.7% |
|
ARCELLX, INC. | 3.8% | 1.8% | 1.8% |
|
REVOLUTION MEDICINES, INC. | 3.7% | 1.7% | 1.7% |
 |
BIONTECH SE SPONSORED ADR | 3.7% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to CNCR
 |
BEIGENE, LTD. | 6.2% |
 |
ROCHE HOLDING LTD | 5.5% |
 |
SANOFI-AVENTIS | 5.4% |
 |
GSK PLC | 5.3% |
|
ASTRAZENECA PLC | 5.1% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 4.9% |
 |
GENMAB A/S | 4.3% |
|
INCYTE CORP | 3.8% |
|
TWIST BIOSCIENCE CORP. | 3.6% |
|
MODERNA, INC. | 3.3% |
IDNA Underweight Relative to CNCR
|
RECURSION PHARMACEUTICALS, INC CLASS | -3.6% |
|
INTREXON CORP | -3.2% |
|
GENELUX CORP. | -2.5% |
|
BRISTOL-MYERS SQUIBB CO | -2.4% |
|
COMPASS THERAPEUTICS, INC. | -2.4% |
|
2SEVENTY BIO, INC. | -2.1% |
|
BLUEPRINT MEDICINES CORP. | -2.1% |
|
SCHRODINGER, INC. | -2.0% |
|
REPLIMUNE GROUP, INC. | -2.0% |
|
ZYMEWORKS INC. | -2.0% |